Stay updated on IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Sign up to get notified when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.

Latest updates to the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check20 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check64 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference0.9%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
Stay in the know with updates to IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.